Business Sanofi and Verily pair up to improve diabetes treatment French drugmaker Sanofi and the US firm Verily are to invest around $500 million (445 million euros) in a joint venture to help people with diabetes. 12/09/2016
Business Sanofi earnings to be 'stable' despite declining sales French drugmaker Sanofi has pledged its 2016 earnings will be stable despite declining sales of diabetes and cancer treatments. 09/02/2016
